Overview

Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)

Status:
Completed
Trial end date:
2015-01-28
Target enrollment:
Participant gender:
Summary
Phase 4 Study to evaluate the safety and effect on decreasing subjects' albuminuria who have Type 2 Diabetes by using sarpogrelate and placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Sarpogrelate